On Wednesday, June 16 , in webinar format, a dialogue took place with the director of innovation of the pharmaceutical company Reig Jofre to show how the situation we are experiencing with Covid-19 and the manufacture of vaccines serves as a catalyst in research in new technologies for the future.
The aim of the DI Dialogues is to know the vision of different personalities of the productive fabric of the country and the academic world on collaborative research, talent, research and its impact on society, and the role played by Industrial Doctorates in all this.
Society is becoming more and more complex, and so are the problems and challenges we face, of which we have a very serious example with the pandemic that we have had to live with. This complexity makes research more and more specialized and, therefore, more expensive. The need to put different researchers together, with different expertise, and who work in different sectors, makes collaborative research a necessity and, at the same time, an option to face the future.
"Vaccines and COVID-19: Catalysts for research in future technologies"
Dr. Albert Sangrà, director of the Industrial Doctorates Plan, has spoken with Isabel Amat Riera, Director of Innovation at the pharmaceutical company Reig Jofre. Reig Jofre's new plant in Barcelona of injectables is almost about to start this June with the manufacture of janssen's Covid-19 vaccine (Johnson &Johnson group). This DI Dialogue wants to show how the situation we are experiencing with Covid-19 and the manufacture of vaccines serves as a catalyst for research into new technologies for the future.